Metrion Biosciences Limited

About Metrion Biosciences Limited

Metrion Biosciences is a specialist preclinical drug discovery contract research organization (CRO) focused on delivering high-quality services, expert advice, and outstanding customer support to empower the success of their customers' pharmaceutical research and development.

Products & Services

Ion Channel Screening:Services for screening ion channels, including high-throughput screening to support drug discovery.

Cardiac Safety Screening:Comprehensive cardiac safety assessments including GLP hERG testing, hiPSC-derived cardiomyocyte assays, and CiPA screening to evaluate drug-induced cardiac risks.

Neuroscience Services:Specialized services for CNS drug discovery, including brain slice tissue studies, native neuronal ion channel research, central neuronal firing, pain research, and translational assays.

Integrated Drug Discovery:End-to-end drug discovery services combining expertise and tailored approaches for pharmaceutical research.

Specialties

Ion Channel Screening Cardiac Safety Screening Neuroscience Research Integrated Drug Discovery Pain Research CNS Drug Discovery Electrophysiology Expertise

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Equity Financing T: - FT: Equity Financing	A: 4680000 MR: - FA: £3.7m FAN: 4680000	D: 2023-12-20 FD: 2023-12-20	2 investors

Equity Financing Latest

2023-12-20

$4.7M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

John Gilchrist

Principal Scientist

D

Dinah Misner

VP

M

Marc Rogers

Founding Director

J

John Ford

Non-executive Director

K

Keith McCullagh

Non-Executive Chairman

L

Lee Patterson

Chief Executive Officer

View 14 more team members with Pro

Unlock Full Team Directory

Recent News